跳至主要内容
临床试验/NCT06282016
NCT06282016招募中不适用

Risk Factors for Neuroendocrine Neoplasms: a Case-control Study Based on a Record Linkage of Registry and Claims Data

Bavarian Cancer Registry1 个研究点 分布在 1 个国家目标入组 14,250 人开始时间: 2025年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
14,250
试验地点
1
主要终点
Assured NEN diagnosis of the BPS

研究概览

简要总结

Recent studies show an increase in neuroendocrine neoplasms, especially for the digestive tract. Previous studies suggest various risk factors that were observed for various tumor sites, e.g. a family history of cancer, tobacco and alcohol consumption as well as metabolic disorders including diabetes and obesity. A risk factor that has been little studied to date is depressive disorders, which could increase the risk of neuroendocrine neoplasms either independently or through associated risk behaviors and/or antidepressant medication. The aim of this study is to identify risk factors for neuroendocrine neoplasms based on a case-control study in order to better understand the increase of neuroendocrine neoplasms in recent decades. The study is based on a record linkage of data from the Bavarian Cancer Registry and data from the Bavarian Association of Statutory Health Insurance Accredited Physicians. While the data from the Bavarian Cancer Registry enables the identification of neuroendocrine neoplasms on the basis of histopathological findings and thus is the basis for selecting cases, the claims data from the Bavarian Association of Statutory Health Insurance Accredited Physicians provides the source population as well data on diagnoses and thus enables the investigation of risk factors.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Persons with a statutory health insurance (about 85% of the population) and at least one outpatient physician contact in Bavaria between 2021 and 2023
  • Residence in Bavaria

排除标准

  • 未提供

结局指标

主要结局

Assured NEN diagnosis of the BPS

时间窗: 2021-2023

Neuroendocrine neoplasm of the bronchopulmonary system

Assured NEN diagnosis of the GEPS

时间窗: 2021-2023

Neuroendocrine neoplasm of the gastroenteropancreatic system

次要结局

  • Assured NET diagnosis of the BPS(2021-2023)
  • Assured NEC diagnosis of the BPS(2021-2023)
  • Assured NEC diagnosis of the GEPS(2021-2023)
  • Assured NET diagnosis of the GEPS(2021-2023)

研究者

发起方
Bavarian Cancer Registry
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验